tm
Seeing Is Believing
tm
Seeing Is Believing
EFTR is currently covered by 3 analysts
Effector Therapeutics's activity chart (see below) currently has 12 price targets and 20 ratings on display. The stock rating distribution of EFTR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 35% with an average time for these price targets to be met of 235.6 days.
Highest price target for EFTR is $1, Lowest price target is $1.
Most recent stock forecast was given by BENJAMIN BURNETT from STIFEL on 26-May-2023. First documented stock forecast 13-Sep-2021.
Currently out of the existing stock ratings of EFTR, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$1.3
$0.13 (11.11%)
3 years 3 months 15 days ago
(26-May-2023)
1/3 (33.33%)
$0.64 (96.97%)
11
Buy
3 years 4 months ago
(10-May-2023)
2/3 (66.67%)
$9.66 (222.58%)
740
Buy
$1
$-0.17 (-14.53%)
$2
3 years 8 months 1 days ago
(09-Jan-2023)
3/4 (75%)
$0.6 (150.00%)
427
Buy
4 years 3 months 4 days ago
(06-Jun-2022)
0/2 (0%)
$30.7 (159.07%)
Buy
4 years 5 months 6 days ago
(04-Apr-2022)
0/1 (0%)
$7.79 (63.80%)
What is EFTR (Effector Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on EFTR (Effector Therapeutics)?
Which analyst has the current lower performing score on EFTR (Effector Therapeutics) with a proven track record?
Which analyst has the most public recommendations on EFTR (Effector Therapeutics)?
Which analyst is the currently most bullish on EFTR (Effector Therapeutics)?
Which analyst is the currently most reserved on EFTR (Effector Therapeutics)?
